Drug Trial Radar · NCT07335536
The Efficacy of Remimazolam on Incidence of Hypoxia During Sedated Transvaginal Oocyte Retrieval
Last checked: Nov 19, 2026Latest source record: Oct 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
400
Actual
Start
Oct 20, 2025
Primary completion
Sep 1, 2026
Study completion Oct 1, 2026
Sponsor
- Lead sponsor
- Diansan SuAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jan 13, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- Female only, from 18 years, up to 50 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Hypoxia is the most common adverse reaction during sedation outside the operating room.Exploring novel drug combinations to reduce the incidence of hypoxia during sedation in patients undergoing transvaginal oocyte retrieval procedures enhances patient safety and lowers perioperative adverse event rates. This multicenter, prospective, randomized, controlled clinical study will compare the hypoxia incidence rate of the remimazolam-alfentanil combination against the commonly used propofol-alfentanil combination.
Conditions
- Hypoxia
- Infertility
- Infertility Assisted Reproductive Technology
Interventions
remimazolam-alfentanil combinationDrug
Administer 7 μg/kg of alfentanyl first,then given remimazolam 0.2 mg/kg (1-minute bolus), followed by 1 mg/kg/h infusion.
propofol-alfentanilDrug
Administer 7 μg/kg of fentanyl first,then given propofol 2 mg/kg (1-minute bolus), followed by 6 mg/kg/h infusion.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of HypoxiaTime frame: Patients will be followed for the duration of hospital stay, an expected average about 2 hours
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Dongyang People's Hospital
Dongyang, Zhejiang, China
The First Affiliated Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.